Citius Pharmaceuticals is trading at $0.60 (+10.89%); no fresh company-specific catalyst was found for the move. - Healthcare rose 2.32% during the session, while major U.S. indices were lower. - The latest company-specific update, released October 26, reported preliminary LYMPHIR wholesaler shipments of 792 units, up 120% sequentially; this was not a new October 29 announcement.